Volume 2
Buch, Englisch, 219 Seiten, Format (B × H): 155 mm x 235 mm, Gewicht: 394 g
ISBN: 978-3-030-67764-0
Verlag: Springer International Publishing
This volume provides the reader with a detailed overview of the current state-of-the art approach of Hepatitis C management. It reviews the course of action in handling of chronic Hepatitis C patients with various HCV genotypes and treats special cases such as acute hepatitis, transplant and renal patients as well as people who inject drugs.
The two volume work on Hepatitis C introduces to the topic by reviewing virology, diagnosis, epidemiology, prevention, management and elimination of HCV. The book provides a valuable source at full length for researchers and clinicians working on Hepatitis C.
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Medizinische Mikrobiologie & Virologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Präventivmedizin, Gesundheitsförderung, Medizinisches Screening
- Naturwissenschaften Biowissenschaften Virologie
Weitere Infos & Material
Assessment of liver disease severity.- Hepatitis C and autoimmunity.- Extrahepatic manifestations.- Treatment indications and pretreatment assessment.- Available agents - contraindications and potential drug-drug interactions.- Current management of patients with HCV genotype 1.- Current management of patients with HCV genotype 2.- Current management of patients with HCV genotype 3.- Current management of patients with HCV genotype 4.- Current management of patients with HCV genotype 5 or 6.- The role of RAVs in the current management of HCV.- Management of patients with HCV decompensated cirrhosis.- Management of patients with acute hepatitis C.- Management of transplant patients.- Management of immune complex-mediated manifestations of HCV.- Management of patients with co-infections (HBV, HIV).- Management of patients under hemodialysis.-Management of active drug addicts or patients on maintenance substitution.- Management of patients with hemoglobinopathies or bleeding disorders.- Follow-up during and after treatment.
